Signaturefd, LLC Zentalis Pharmaceuticals, Inc. Transaction History

Signaturefd, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$10.83 - $16.49 $184 - $280	17 Added 56.67%	47 $0
Q4 2023 Jan 31, 2024	SELL	$9.84 - $20.13 $206 - $422	-21 Reduced 41.18%	30 $0
Q3 2023 Nov 03, 2023	SELL	$19.63 - $28.29 $235 - $339	-12 Reduced 19.05%	51 $1,000
Q2 2023 Aug 01, 2023	SELL	$17.41 - $30.05 $208 - $360	-12 Reduced 16.0%	63 $1,000
Q4 2022 Jan 27, 2023	SELL	$18.07 - $25.6 $180 - $256	-10 Reduced 11.76%	75 $1,000
Q2 2022 Aug 10, 2022	BUY	$17.91 - $52.25 $1,522 - $4,441	85 New	85 $2,000
Q1 2022 May 02, 2022	SELL	$41.58 - $80.89 $1,039 - $2,022	-25 Closed	0 $0
Q4 2021 Jan 25, 2022	BUY	$66.92 - $84.79 $1,673 - $2,119	25 New	25 $2,000
Q3 2021 Oct 28, 2021	SELL	$46.83 - $73.5 $749 - $1,176	-16 Closed	0 $0
Q2 2021 Jul 26, 2021	BUY	$37.41 - $62.25 $598 - $996	16 New	16 $1,000

142

67.9M

48.5K

89.6K

Ticker ZNTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,983,600
Market Cap $171M
Description
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.